Problem of urogenital mixed infections in reproductive aged women in current gynecology
Keywords:urogenital mixed infection, conditionally pathogenic microflora, pelvic inflammatory diseases
A tendency of annual growth in inflammatory diseases of female genital organs is being observed now, and these diseases have a long-term recrudescent character with the inflammatory process chronization. Physicians of all specialties in a world medical practice prefer the term “pelvic inflammatory disease”.
Goal of this literature review was to generalize the up-to-date data on the problem of the urogenital mixed infections in women of reproductive age. Reviewing both foreign and domestic literature sources published in recent 10 years on the problem of urogenital mixed infections in women of reproductive age.
Рelvic inflammatory diseases is a group of diseases (independent nosological entities) of the upper region of female reproductive tract that combine endometritis, salpingitis, oophoritis, tubo-ovarian abscess and pelvis peritonitis. The highest it risks was noticed among the younger women of reproductive age (below 25) with unprotected sexual relationships and numerous sexual partners.
Three different levels of genital organ disorders are distinguished dependent of the infection process localization: the lower level, the upper level and the mixed one, i.e. the combination of the lower and the upper levels. Vulvitis, vulvovaginitis, vaginitis and endocervicitis belong to the lower level of genital organ disorders, salpingo-oophoritis, endometritis, metroendometritis and pelvioperitonitis belong to the upper one, while the mixed level includes disorders of both upper and lower genital tracts. Considerable anatomic and functional changes in pelvic organs are formed in 1–2 years from the moment of the genital inflammatory disease beginning and traditionally are not detected at the initial stages of their progress, being, in most cases, accompanied by the reproductive and sexual health disorders.
The mucous membranes of urinary tracts, vagina and uterine cervix are populated by various microorganisms that are in a constant antagonism or synergism with each other. Colonization resistance of the vagina and urinary tract mucous membranes provides the natural microbiocenosis stability, prevents pathogenic microorganism colonization and active reproduction of the conditionally pathogenic microflora.
- Dovlethanova, E.R., Abakarova, P.R. “Possibility of applying the complex preparations in treating the vulvovaginitis of polymicrobial etiology.” Obstetrics and gynecology 4 (2012): 8–11.
- Saghi-Nejad, H., Wasstrman, M., Weidner, W., et al. “Sexually transmitted diseases and sexual function.” Journal of Sexual Medicine 7 (2010): 389–413.
- Ledger, W., Witkin, S. Vulvovaginal infection. Manson Publishing Ltd. (2010): 127 p.
- Markos, A.R. “The concordance of Chlamydia trachomatis genital infection between sexual partners, in the era of nucleic acid testing.” Sex Health 2 (2009): 23–4.
- World Health Organization. Global prevalence incidence of selected curable sexually transmitted infections. Geneva. WHO (2012).
- Pennehouat, G., Joly-Guilou, M.I., Mohseni, H., et al. “Treatment of genital infections in gynecology.” Gynecol Obstet Fertil 30.9 (2009): 744–9.
- Henry-Suchet, J. L’infection en gynecologie. Paris (2009): 176 p.
- Romashchenko, O.V., Rudenko, A.V., Biloholovska, V.V., et al. “Diagnostics of the urinary tract and genital organs inflammatory diseases in females.” In: Collection of scientific works of the Ukrainian Association of Obstetricians and Gynecologists. Kyiv. Intermed (2009) 271–273.
- Rudenko, A.V., Romashchenko, O.V., Romanenko, A.M., et al. “The role of infectious factors in forming disorders of the family reproductive health.” PAG 2 (2009): 65–8.
- Workowski, K.A., Berman, S.M. “Sexually transmitted diseases treatment guidelines.” MMWR Recomm Rep 55 (2009): 1–94.
- Romashchenko, O.V.“Revaluation of approaches to the diagnostics and treatment of the genital organs inflammatory diseases caused by the Chlamydia infection taking into account European recommendations.” Reproductive endocrinology 1.3 (2012): 51–8.
- Larsen, B. “Microbiology of the female genital tract.” In: Obstetric and Gynecologic Infections Diseases, ed. by J. Pastorek. New York. Raven Press (2009): 11–26.
- Eschenbach, D.A., Davick, P.R., Willams, D.L., et al. “Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis.” J Clin Microbiol 27 (2010): 251–6.
- Penney, G.C., Thompson, M., Norman, J., et al. “A randomized comparison of strategies for reducing infective complications of induced abortion.” Br J Obstet Gynecol 105 (2010): 599–604.
- Evidentiary medicine. Annual international handbook. Issue 2, part 5. Translated from English. Moscow. Media Sphere (2013).
- Mazzulli, T. “Resistance trends in urinary tract pathogens and impact on management.” J Urol 168.4.2 (2012): 1720–2.
- Romashchenko, O.V., Vozianova, S.V., Rudenko, А.V. “Treatment of PID caused by the mixed infection.” Women health 6 (2016): 34–42.
- Lopatkin, N.A., Derevianko, I.I., Nefedova, L.A. “Etiological structure and treatment of infectious inflammatory complications in the urological practice.” In: Materials of the Plenum of Russian Urological Society. Kirov (2011): 5–29.
- Savicheva, А.М., Bashmakova, М.А. Urogenital chlamydiosis in females and its consequences. Nizhniy Novgorod (2010): 3–89.
- Stamm, W.E., et al. “Management of urinary tract infections in adults.” N Engl J Med 329.18 (2012): 1328–34.
- Lapach, S.N., Chubenko, А.V., Babich, P.N. Statistical methods in medical and biological studies using Ехсеl. Кyiv. Morion (2010): 319 p.
- Johannisson, A., Festin, R. “Phenotype transition of CD4+ T cells from CD45RO is accompanied by cell activation and proliferation.” Cytometry 19 (2013): 343–52.
- Radzinsky, V.Е., Ordiants, I.М., Pobedinskaya, О.S., Buyanova, N.V. “Modern aspects of disbiotic disorder correction in the gynecological practice.” Obstetrics and gynecology 2 (2013): 72–76.
- Kisina, V.I. “Vaginal infections: clinical value and treatment.” Dermatovenerology and dermatocosmetology 1 (2011): 28–33.
- Blinov, D.V. “Vaginal infections – from diagnostics to rational complex therapy.” Obstetrics, gynecology and reproduction 5.4 (2011): 44–7.
- Gupta, K., Trautner, B.W. “Diagnosis and management of recurrent urinary tract infections in non-pregnant women.” BMJ 346 (2013): f3140. DOI: 10.1136/bmj.f3140
- Rossignol, L., Vaux, S., Maugat, S., et al. “Incidence of urinary tract infections and antibiotic resistance in the outpatient setting: a cross-sectional study (n.d.).” Infection 45.1 (2017): 33–40. DOI: 10.1007/s15010-016-0910-2
- Hooton, T.M. “Uncomplicated Urinary Tract Infection.” N Engl J Med 366 (2012): 1028–37. DOI: 10.1056/NEJMcp1104429
- Keren, R., Shaikh, N., Pohl, H., et al. “Risk Factors for Recurrent Urinary Tract Infection and Renal Scarring.” Pediatrics 136 (2015): e13–21. DOI: 10.1542/peds.2015-0409
- Guglietta, A. “Recurrent urinary tract infections in women: risk factors, etiology, pathogenesis and prophylaxis.” Future Microbiol 12 (2017): 239–46. DOI: 10.2217/fmb-2016-0145
- Nicole, L.E. “Urinary Tract Infections in the Older Adult.” Clin Geriatr med 32 (2016): 523–38. DOI: 10.1016/j.cger.2016.03.002
- Horner, P.J., Blee, K., Falk, L., et al. “European guideline on the management of non-gonococcal urethritis.” Int J STD AIDS 27 (2016): 928–37. DOI: 10.1177/0956462416648585
- Horner, P.J., Blee, K., O’Mahony, C., et al. “UK National Guideline on the management of non-gonococcal urethritis.” Int J STD AIDS 27 (2016): 85–96. DOI: 10.1177/0956462415586675
- Shapiro, T., Dalton, M., Hammock, J., et al. “The Prevalence of Urinary Tract Infections and Sexually Transmitted Disease in Women with Symptoms of a Simple Urinary Tract Infection Stratified by Low Colony Count Criteria.” Acad Emerg Med 12 (2009): 38–44. DOI: 10.1111/j.1553-2712.2009.tb01476.x
- Bader, M.S., Loeb, M., Brooks, A.A. “An update on the management of urinary tract infections in the era of antimicrobial resistance.” Postgrad Med 129 (2017): 242–58. DOI: 10.1080/00325481.2017.1246055
- Al Majid, F., Buba, F. “The Predictive and Discriminant Values of Urine Nitrites in Urinary Tract Infection.” Biomedical Research 21.3 (2010).
- Tomas, M.E., Getman, D., Donskey, C.J., Hecker, M.T. “Overdiagnosis of Urinary Tract Infection and Underdiagnosis of Sexually Transmitted Infection in Adult Women Presenting to an Emergency Department.” J Clin Microbiol 53 (2015): 2686–92. DOI: 10.1128/JCM.00670-15
- Dyar, O.J., Huttner, B., Schouten, J., Pulcini, C. “What is antimicrobial stewardship?” Clin Microbiol Infect 23 (2017): 793–8. DOI: 10.1016/J.CMI.2017.08.026
- Teede, H.J., Misso, M.L., Costello, M.F., et al. “Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.” Hum Reprod 33 (2018): 1602–18. DOI: 10.1093/humrep/dey256
- Kauffman, C.A. “Diagnosis and Management of Fungal Urinary Tract Infection.” Infect Dis Clin North Am 28 (2014): 61–74. DOI: 10.1016/j. idc.2014.09.004
- Hilt, E.E., McKinley, K., Pearce, M.M., et al. “Urine Is Not Sterile: Use of Enhanced Urine Culture Techniques To Detect Resident Bacterial Flora in the Adult Female Bladder.” J Clin Microbiol 52 (2014): 871–6. DOI: 10.1128/JCM.02876-13
- LaRocco, M.T., Franek, J., Leibach, E.K., et al. “Effectiveness of Preanalytic Practices on Contamination and Diagnostic Accuracy of Urine Cultures: a Laboratory Medicine Best Practices Systematic Review and Meta-analysis.” Clin Microbiol Rev 29 (2016): 105–47. DOI: 10.1128/CMR.00030-15
How to Cite
Copyright (c) 2019 N. Y. Bysaha, О. О. Korchynska
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.